Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Thyroid Eye Disease – What to Expect
source: Kellogg Eye Center / University of Michigan Health
year: N/A
summary/abstract:How does the disease progress?
There are two phases. The active phase, marked by inflammation, usually lasts from six months to two years. The focus during this stage is on medical treatment to relieve the eye symptoms. During the second phase, or the stable phase, inflammation and other symptoms have subsided. The patient may need surgery to correct the more visible effects of the disease.
read more
myBinderRelated Content
-
Knowledge of Thyroid Eye Disease in Graves’ Disease Patients With and Without OrbitopathyBackground: Thyroid eye disease (TED) d...
-
“TED Today” Episode 2https://www.facebook.com/111185326929227...
-
Radioiodine Ablation of Postsurgical Thyroid Remnants After Treatment With Recombinant Human TSH (rhTSH) in Patients...Context: Recent evidence suggests thyro...
-
Thyroid-Associated Ophthalmopathy After Treatment for Graves’ Hyperthyroidism With Antithyroid Drugs or Iodine...Context: Previous randomized trials hav...
-
No Need to Suffer From Double Vision With Graves’ Diseasehttps://www.youtube.com/watch?v=cQ7-Yi5t...
-
FDA Committee Unanimously Recommends Approval of Teprotumumab for Thyroid Eye DiseaseThe Dermatologic and Ophthalmic Drugs Ad...
-
Thyroid Eye DisordersWhat is the Thyroid? The thyroid is a b...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Google